Fuggetta Gianluca has filed 4 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 50000 shares of Gain Therapeutics, Inc. ($GANX) on March 24, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 24, 2026 | Gain Therapeutics, Inc. | $GANX | Fuggetta Gianluca | See Remark | A | Employee Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 34,998,060 | 9999.99% | 0.14% |
| March 20, 2025 | Gain Therapeutics, Inc. | $GANX | Fuggetta Gianluca | See Remark | A | Employee Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 22,881,415 | 9999.99% | 0.22% |
| March 21, 2024 | Gain Therapeutics, Inc. | $GANX | Fuggetta Gianluca | See Remark | A | Employee Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 13,011,361 | 9999.99% | 0.38% |
| March 23, 2023 | Gain Therapeutics, Inc. | $GANX | Fuggetta Gianluca | Principal Accounting Officer | A | Employee Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 11,883,368 | 9999.99% | 0.13% |